Những nghiên cứu mới về vắc-xin (Cập nhật đến ngày 8/12/2023)

Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về vaccine COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống cập nhật đến ngày 8/12/2023.

1. Sciencedirect

1. Psychometric development of the COVID-19 vaccine misinformation scale and effects on vaccine hesitancy
Preventive Medicine Reports 6 December 2022
Stephen Bok, Daniel Martin, Maria Lee
https://www.sciencedirect.com/science/article/pii/S2211335522003941/pdfft?md5=cc1b22db1a4c49f276e148f15aadb27d&pid=1-s2.0-S2211335522003941-main.pdf

2. What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector
Vaccine 25 November 2022
Arno Stöcker, Jan Hoffmann, Nadine Scholten
https://www.sciencedirect.com/science/article/pii/S0264410X22014669/pdfft?md5=64a228a2a0fb74912b4045ec188f7ad7&pid=1-s2.0-S0264410X22014669-main.pdf

3. Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach
Expert Systems with Applications 19 May 2023
Eyüp Ensar Işık, Seyda Topaloglu Yildiz
https://www.sciencedirect.com/science/article/pii/S0957417423010126/pdfft?md5=b1485cd432a503832bb0818d6551b8a7&pid=1-s2.0-S0957417423010126-main.pdf

4. Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: an ecological study in Japan
Public Health 4 October 2023
T. Ando, Y. Ibuka, S. Fujishima
https://www.sciencedirect.com/science/article/pii/S0033350623003268/pdfft?md5=06c1f3124692ea3cdba2879208d52dd5&pid=1-s2.0-S0033350623003268-main.pdf

5. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
Biomedicine & Pharmacotherapy 3 August 2023
Jakub Wroński, Marzena Ciechomska, Ewa Kuca-Warnawin
https://www.sciencedirect.com/science/article/pii/S0753332223010454/pdfft?md5=4c90e9ee6ce76db10e3dcb7789043903&pid=1-s2.0-S0753332223010454-main.pdf

6. Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink
Vaccine 20 July 2023
W. Katherine Yih, Matthew F. Daley, Judith C. Maro
https://www.sciencedirect.com/science/article/pii/S0264410X2300823X/pdfft?md5=ab2628d30415802461bc12ac8ddea9dd&pid=1-s2.0-S0264410X2300823X-main.pdf

7. A national nudge study of differently framed messages to increase COVID-19 vaccine uptake in Saudi Arabia: A randomized controlled trial
Saudi Pharmaceutical Journal 15 August 2023
Mohammed Alhajji, Abdullah H. Alzeer, Fahad Alsaawi
https://www.sciencedirect.com/science/article/pii/S1319016423002438/pdfft?md5=293d0bf6142f3907d2b52688f7c76a42&pid=1-s2.0-S1319016423002438-main.pdf

8. Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study
The Lancet Infectious Diseases 20 June 2023
Dan Yamin, Matan Yechezkel, Erez Shmueli
https://www.sciencedirect.com/science/article/pii/S1473309923002074/pdfft?md5=b9dbe79bb12120645069898c4133c253&pid=1-s2.0-S1473309923002074-main.pdf

9. COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study
Vaccine: X 7 January 2023
Patrick Diox Ouni, Racheal Namulondo, David Mukunya
https://www.sciencedirect.com/science/article/pii/S2590136223000013/pdfft?md5=1022adfdf10e43c54482ed46c99eba21&pid=1-s2.0-S2590136223000013-main.pdf

10. Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients
Cytokine 4 September 2023
Débora Familiar-Macedo, Paulo Vieira Damasco, Luzia Maria de-Oliveira-Pinto
https://www.sciencedirect.com/science/article/pii/S1043466623002284/pdfft?md5=b3c07a9239d9250d8ab5da48e7c644d8&pid=1-s2.0-S1043466623002284-main.pdf

11. Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States
Vaccine 13 January 2023
Saurabh Kalra, Deepak Kalra, Soumitra S. Bhuyan
https://www.sciencedirect.com/science/article/pii/S0264410X2300035X/pdfft?md5=d9e8ed12fef18add34e627f97b8e7a6b&pid=1-s2.0-S0264410X2300035X-main.pdf

12. Key factors influencing paediatric COVID-19 vaccine hesitancy: a brief overview and Decision-making Trial and Evaluation Laboratory analysis
Public Health 28 November 2022
Y. Wang, X. Zhang
https://www.sciencedirect.com/science/article/pii/S0033350622003316/pdfft?md5=920c3850f395037cd60c531142799427&pid=1-s2.0-S0033350622003316-main.pdf

13. Knowledge and attitudes toward the COVID-19 vaccine among India's general rural population
Vacunas (English Edition) 3 May 2023
Rajesh Venkataraman, Umesh Yadav, Shree Harsha Pura Basavaraju
https://www.sciencedirect.com/science/article/pii/S2445146023000249/pdfft?md5=4c400feffd145a146266e27fada861b7&pid=1-s2.0-S2445146023000249-main.pdf

14. A fractional-order mathematical model for examining the spatiotemporal spread of COVID-19 in the presence of vaccine distribution
Healthcare Analytics 20 July 2023
Adedapo Ismaila Alaje, Morufu Oyedunsi Olayiwola
https://www.sciencedirect.com/science/article/pii/S2772442523000977/pdfft?md5=3a5c69d4c0bbb3156816dde2f9f433cf&pid=1-s2.0-S2772442523000977-main.pdf

15. Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada
Vaccine 7 April 2023
J. Leigh Hobbs, Lauren A. Paul, Sarah E. Wilson
https://www.sciencedirect.com/science/article/pii/S0264410X23003894/pdfft?md5=056b57a414406ca9e58e8504afd7d9ff&pid=1-s2.0-S0264410X23003894-main.pdf

16. Impacts of the COVID-19 pandemic on immunization with pneumococcal vaccines in children and older adults in Brazil
Preventive Medicine 7 July 2023
João Vitor Levindo Coelho Novaes, Flavia Maria de Freitas Faria, Luara Isabela dos Santos
https://www.sciencedirect.com/science/article/pii/S0091743523001822/pdfft?md5=d35348982a1f7ef976d4380995e1ae65&pid=1-s2.0-S0091743523001822-main.pdf

17. Socioeconomic status and disparities in COVID-19 vaccine uptake in Eastern Oslo, Norway
Public Health in Practice 28 May 2023
Andreas Lillebråten, Megan Todd, Svenn-Erik Mamelund
https://www.sciencedirect.com/science/article/pii/S266653522300037X/pdfft?md5=93ee8df473f11f686e9cc41bd5a0beb7&pid=1-s2.0-S266653522300037X-main.pdf

18. Instilling Confidence in the COVID-19 Vaccine
Nursing Clinics of North America 7 November 2022
Kristine Gonnella, Deepa Mankikar
https://www.sciencedirect.com/science/article/pii/S0029646522033849/pdfft?md5=cc76b3e9b0b0dc0d81c1280e4fc70dba&pid=1-s2.0-S0029646522033849-main.pdf

19. Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study
Vaccine 1 February 2023
Kristin L. Andrejko, Jennifer F. Myers, Jake M. Pry
https://www.sciencedirect.com/science/article/pii/S0264410X23001081/pdfft?md5=918a579e975ca1f23b993909152cf765&pid=1-s2.0-S0264410X23001081-main.pdf

20. Reducing barriers to COVID-19 vaccine uptake through a culturally sensitive pharmacy-led patient medication education group in a behavioral health population
Journal of the American Pharmacists Association 27 January 2023
Ina Liu, Aliyah Cruz, Suzanne C. Harris
https://www.sciencedirect.com/science/article/pii/S1544319123000134/pdfft?md5=4d8a5797753cc0874a821cce33c4537f&pid=1-s2.0-S1544319123000134-main.pdf

21. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases
Journal of Clinical Virology 10 July 2023
Shi Zhao, Zihao Guo, Eng-Kiong Yeoh
https://www.sciencedirect.com/science/article/pii/S1386653223001701/pdfft?md5=69f82d4517781176dfbf9affff482d81&pid=1-s2.0-S1386653223001701-main.pdf

22. The status of COVID-19 vaccines in India: A review
Vacunas 25 April 2023
Deepak Kumar Jha, Kumar Pranay, Niti Yashvardhini
https://www.sciencedirect.com/science/article/pii/S2445146023000419/pdfft?md5=e02cc5674d49a6a6331c03349e60f834&pid=1-s2.0-S2445146023000419-main.pdf

23. COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study
Vaccine 2 March 2023
Kamila M. Ludwikowska, Aneta Popiel, Leszek Szenborn
https://www.sciencedirect.com/science/article/pii/S2445146023000419/pdfft?md5=e02cc5674d49a6a6331c03349e60f834&pid=1-s2.0-S2445146023000419-main.pdf

24. Factors associated with US caregivers’ uptake of pediatric COVID-19 vaccine by race and ethnicity
Vaccine 6 March 2023
Rebecca J. Hart, Shannon Baumer-Mouradian, Ran D Goldman
https://www.sciencedirect.com/science/article/pii/S0264410X23002426/pdfft?md5=5431221bef584f34a612eb2558064d43&pid=1-s2.0-S0264410X23002426-main.pdf

25. Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China
Vaccine Available online 17 October 2023
Hui Yang, Zhaojian Wang, Zhaohui Tong
https://www.sciencedirect.com/science/article/pii/S0264410X23012197/pdfft?md5=a59cab17625455cd4d1135202bc560c0&pid=1-s2.0-S0264410X23012197-main.pdf

26. Association between caregiver opposition to topical fluoride and COVID-19 vaccines
Vaccine 14 December 2022
Sapna J. Saini, Adam C. Carle, Donald L. Chi
https://www.sciencedirect.com/science/article/pii/S0264410X22015328/pdfft?md5=80d9edf8f3a3360f6e03dee35b8eb2cd&pid=1-s2.0-S0264410X22015328-main.pdf

27. Prevalence, predictors and reasons for COVID-19 vaccine hesitancy: Results of a global online survey
Health Policy 19 August 2023
Paolo Candio, Mara Violato, Laurence SJ Roope
https://www.sciencedirect.com/science/article/pii/S016885102300180X/pdfft?md5=bdedbc9a1d8101cd965f17494f6984c5&pid=1-s2.0-S016885102300180X-main.pdf

28. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19
Mathematical Biosciences 16 February 2023
Hemaho B. Taboe, Michael Asare-Baah, Calistus N. Ngonghala
https://www.sciencedirect.com/science/article/pii/S0025556423000226/pdfft?md5=cb00580c16e91f5f1709fe58aaca8528&pid=1-s2.0-S0025556423000226-main.pdf

29. Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study
The Lancet Infectious Diseases Available online 2 August 2023
Celine Y Tan, Calvin J Chiew, Kelvin Bryan Tan
https://www.sciencedirect.com/science/article/pii/S1473309923003730/pdfft?md5=c70a82dae2da0d1d29a23691cf9991fd&pid=1-s2.0-S1473309923003730-main.pdf

30. A vaccine for volatility? An empirical analysis of global stock markets and the impact of the COVID-19 vaccine
The Journal of Economic Asymmetries 9 September 2023
Niall O'Donnell, Darren Shannon, Barry Sheehan
https://www.sciencedirect.com/science/article/pii/S1703494923000439/pdfft?md5=fbf9012fc0dd5a1cb4069d46af5b2bd4&pid=1-s2.0-S1703494923000439-main.pdf

31. Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey
The Lancet Global Health 21 December 2022
Nicole Bergen, Katherine Kirkby, Ahmad Reza Hosseinpoor
https://www.sciencedirect.com/science/article/pii/S2214109X22005204/pdfft?md5=1e7763571e40d2bb9081c47d1cdfd7a7&pid=1-s2.0-S2214109X22005204-main.pdf

32. Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Journal of Infection26 May 2023
Rita W. Y. Ng, Ryan K. H. Sze, Paul K. S. Chan
https://www.sciencedirect.com/science/article/pii/S0163445323002980/pdfft?md5=e790951e6bc1a08045d90493b6906de3&pid=1-s2.0-S0163445323002980-main.pdf

33. COVID-19 vaccine decision-making among pregnant and lactating women in Bangladesh
Vaccine 15 May 2023
Rupali J. Limaye, Prachi Singh, Towfida Jahan Siddiqua
https://www.sciencedirect.com/science/article/pii/S0264410X23005510/pdfft?md5=88f75d52dfb85c1dd2a3b3ee8a4adfdd&pid=1-s2.0-S0264410X23005510-main.pdf

34. Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany
Vaccine: X20 April 2023
Céline J. A. van Bilsen, Christina Stabourlos, Christian J. P. A. Hoebe
https://www.sciencedirect.com/science/article/pii/S2590136223000475/pdfft?md5=342ee46a3aa2de1e2fc703ed9240b4a7&pid=1-s2.0-S2590136223000475-main.pdf

35. Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey
Multiple Sclerosis and Related Disorders 30 December 2022
Xu Liu, Kundian Guo, Zhen Hong
https://www.sciencedirect.com/science/article/pii/S2211034822009993/pdfft?md5=0253990c90b6b83e5683dd0dd11867fc&pid=1-s2.0-S2211034822009993-main.pdf

36. Safety and effectiveness of COVID-19 vaccines in patients with IgA nephropathy: a retrospective cohort study from the TriNetX global collaborative networks
eClinicalMedicine 3 November 2023
Cheng-Hsu Chen, Ming-Ju Wu, Shang-Feng Tsai
https://www.sciencedirect.com/science/article/pii/S2589537023004832/pdfft?md5=bbdbf4c24e98544149e2078498df5436&pid=1-s2.0-S2589537023004832-main.pdf

37. Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
Vaccine 29 May 2023
A. Arrospide, M. G. Sagardui, J. Mar
https://www.sciencedirect.com/science/article/pii/S0264410X23006229/pdfft?md5=46421e93c4cb9de18a616cfe09903b6f&pid=1-s2.0-S0264410X23006229-main.pdf

38. Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines
VaccineAvailable online 28 October 2023
Yi LiuStephany Sánchez-OvandoAnnette Fox
https://www.sciencedirect.com/science/article/pii/S0264410X23012173/pdfft?md5=34c176376a3e5a2c12a6e92abdb72efc&pid=1-s2.0-S0264410X23012173-main.pdf

39. Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
Vaccine: X23 March 2023
Hamed HammoudSoha S. AlbayatIheb Bougmiza
https://www.sciencedirect.com/science/article/pii/S259013622300027X/pdfft?md5=40b5c67ccf04985cb652cf9645de792e&pid=1-s2.0-S259013622300027X-main.pdf

40. CONCURRENT PRETIBIAL MYXEDEMA AND THYROID EYE DISEASE FOLLOWING mRNA COVID-19 VACCINE IN A PATIENT WITH HISTORY OF GRAVES’ DISEASE
Annales d'EndocrinologieAvailable online 20 October 2023
Philippe CaronPhilippe ImbertSolange Grunenwald
https://www.sciencedirect.com/science/article/pii/S0003426623007138/pdfft?md5=7e05f7f7e557e82bfe73fc7f3945e50f&pid=1-s2.0-S0003426623007138-main.pdf

41. Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults
Journal of InfectionAvailable online 28 October 2023
Zhili JinJingxuan WuRuihua Dong
https://www.sciencedirect.com/science/article/pii/S0163445323005431/pdfft?md5=9b30e6a233c0da7598470f8919d5a198&pid=1-s2.0-S0163445323005431-main.pdf

42. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Progress in Biophysics and Molecular Biology18 February 2023
Fatemeh BayaniNegin Safaei HashkavaeiYahya Sefidbakht
https://www.sciencedirect.com/science/article/pii/S0079610723000160/pdfft?md5=3b1e7477d7309accc04f86d4f2da2744&pid=1-s2.0-S0079610723000160-main.pdf

Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 8/12/2023